Danone H1 results: Aptamil delivers ‘solid growth’ while Mizone recovers from underperformance in China

By Tingmin Koe

05-Sep-2023 - Last updated on 05-Sep-2023 at 11:26 GMT

Danone has reported ‘solid growth’ in its infant formula brand Aptamil in China for the first six months of 2023, while functional drink brand Mizone has recovered from underperformance after product revamps.

Read the full story here.

NIA top 10 stories

Exclusive China analysis: Consumers spending cautiously but supplement sector holding up well

Great expectations: Kirin targeting Blackmores to hit 100bn yen revenue, 15% profit margin

ASEAN health supplements harmonisation delayed once again, but firms eyeing SEA advised to adopt standards

Japan’s functional food insights: Sleep, stress and skin health claims on the rise – exclusive data

Taiwan FDA to set consumption limits on ashwagandha and seven other botanicals

Asia Pacific growth offsets US’s VMS revenue decline – Centrum, Caltrate maker Haleon

Danone H1 results: Aptamil delivers ‘solid growth’ while Mizone recovers from underperformance in China

Growth agenda: India’s nutraceutical market opportunities ‘far bigger’ than the pharma sector

Calorie crash: Kirin launches immune care postbiotic drink in Japan with 50% less calories

South Korea reviews regulations for nine ingredients, including oat fibre, CoQ10, inulin

Related news

Show more

Follow us

Products

View more

Webinars

On-demand webinars

Nutra Champions Podcast

Nutra Champions Podcast

Headlines